Choate Investment Advisors Eli Lilly & CO Transaction History

Choate Investment Advisors

  • $3.89 Billion
  • Q3 2024

A detailed history of Choate Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Choate Investment Advisors holds 18,450 shares of LLY stock, worth $13.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
18,450
Previous 18,256 1.06%
Holding current value
$13.8 Million
Previous $16.5 Million 1.11%
% of portfolio
0.42%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$772.14 - $960.02 $149,795 - $186,243
194 Added 1.06%
18,450 $16.3 Million
Q2 2024

Aug 08, 2024
SELL
$724.87 - $909.04 $987,272 - $1.24 Million
-1,362 Reduced 6.94%
18,256 $16.5 Million
Q1 2024

May 07, 2024
BUY
$592.2 - $792.28 $8,290 - $11,091
14 Added 0.07%
19,618 $15.3 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $758,899 - $894,642
1,445 Added 7.96%
19,604 $11.4 Million
Q3 2023

Oct 30, 2023
BUY
$434.7 - $599.3 $698,562 - $963,075
1,607 Added 9.71%
18,159 $9.75 Million
Q2 2023

Aug 01, 2023
BUY
$350.74 - $468.98 $70,849 - $94,733
202 Added 1.24%
16,552 $7.76 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $154,072 - $180,950
-496 Reduced 2.94%
16,350 $5.61 Million
Q4 2022

Feb 14, 2023
BUY
$321.55 - $374.67 $613,195 - $714,495
1,907 Added 12.77%
16,846 $6.16 Million
Q3 2022

Nov 14, 2022
SELL
$296.48 - $337.87 $100,210 - $114,200
-338 Reduced 2.21%
14,939 $4.83 Million
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $1.75 Million - $2.06 Million
-6,290 Reduced 29.16%
15,277 $4.95 Million
Q1 2022

Apr 29, 2022
BUY
$234.69 - $291.66 $1.59 Million - $1.98 Million
6,788 Added 45.93%
21,567 $6.18 Million
Q4 2021

Feb 07, 2022
SELL
$224.85 - $279.04 $17,988 - $22,323
-80 Reduced 0.54%
14,779 $4.08 Million
Q3 2021

Nov 04, 2021
SELL
$221.6 - $272.71 $390,016 - $479,969
-1,760 Reduced 10.59%
14,859 $3.43 Million
Q2 2021

Jul 30, 2021
SELL
$180.55 - $233.54 $154,009 - $199,209
-853 Reduced 4.88%
16,619 $3.81 Million
Q1 2021

May 07, 2021
BUY
$164.32 - $212.72 $71,972 - $93,171
438 Added 2.57%
17,472 $3.26 Million
Q4 2020

Feb 08, 2021
BUY
$130.46 - $172.63 $2,739 - $3,625
21 Added 0.12%
17,034 $2.88 Million
Q3 2020

Oct 26, 2020
SELL
$146.22 - $169.13 $63,751 - $73,740
-436 Reduced 2.5%
17,013 $2.52 Million
Q2 2020

Jul 23, 2020
SELL
$136.42 - $164.18 $173,253 - $208,508
-1,270 Reduced 6.78%
17,449 $2.87 Million
Q1 2020

May 07, 2020
SELL
$119.05 - $147.35 $17,857 - $22,102
-150 Reduced 0.79%
18,719 $2.6 Million
Q3 2019

Nov 13, 2019
SELL
$106.79 - $116.16 $26,697 - $29,040
-250 Reduced 1.31%
18,869 $2.11 Million
Q2 2019

Aug 14, 2019
SELL
$110.79 - $129.32 $9,749 - $11,380
-88 Reduced 0.46%
19,119 $2.12 Million
Q1 2019

Apr 29, 2019
SELL
$111.31 - $131.02 $182,882 - $215,265
-1,643 Reduced 7.88%
19,207 $2.49 Million
Q4 2018

Feb 14, 2019
SELL
$105.9 - $118.64 $256,489 - $287,346
-2,422 Reduced 10.41%
20,850 $2.41 Million
Q3 2018

Nov 14, 2018
BUY
$85.86 - $107.31 $120,204 - $150,234
1,400 Added 6.4%
23,272 $2.5 Million
Q2 2018

Jul 30, 2018
SELL
$75.7 - $86.88 $57,002 - $65,420
-753 Reduced 3.33%
21,872 $1.87 Million
Q1 2018

May 04, 2018
SELL
$74.21 - $87.6 $25,528 - $30,134
-344 Reduced 1.5%
22,625 $0
Q4 2017

Feb 14, 2018
SELL
$81.94 - $87.89 $5,899 - $6,328
-72 Reduced 0.31%
22,969 $0
Q3 2017

Nov 14, 2017
BUY
$77.07 - $85.54 $1.78 Million - $1.97 Million
23,041
23,041 $0

Others Institutions Holding LLY

# of Institutions
4,004
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email